Dr Dawn Firmin is responsible for planning, managing and executing the pharmaceutical development of the Company’s programmes and providing leadership to the project teams.
Dawn is a scientific professional with 10 years of combined experience in immunology & infection, toxicology management and the management of drug development of NCEs. Dawn’s expertise lies in her knowledge and experience of managing all preclinical and Phase I activities of the drug development process, including pre-IND meetings.
Dawn was a Post-Doctoral Immunology Research Scientist at the University of Glasgow specialising in a mechanistic in vivo model of Ankylosing Spondylitis. Prior to this she worked for one of the leading Contract Research Organisations, Charles River Laboratories, where she was a Senior Assistant Scientist and Project Manager of toxicology studies. Before joining CRL, she completed her PhD in Immunology and Infection at the University of Aberdeen. Prior to completing her PhD, Dawn also gained an MSc in Medical Diagnostics and graduated from the University of Stirling with a 2.1 Honours degree in Ecology. She has authored and co-authored academic papers and is a member of the Scottish Life Science Association.